BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20031718)

  • 1. Noncardiac surgery and bleeding after percutaneous coronary intervention.
    To AC; Armstrong G; Zeng I; Webster MW
    Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.
    Mehta SK; Frutkin AD; Lindsey JB; House JA; Spertus JA; Rao SV; Ou FS; Roe MT; Peterson ED; Marso SP;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):222-9. PubMed ID: 20031719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
    Nuttall GA; Brown MJ; Stombaugh JW; Michon PB; Hathaway MF; Lindeen KC; Hanson AC; Schroeder DR; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):588-95. PubMed ID: 18813036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
    Rabbitts JA; Nuttall GA; Brown MJ; Hanson AC; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):596-604. PubMed ID: 18813037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
    Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M; Airoldi F; Zimarino M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery.
    Cruden NL; Harding SA; Flapan AD; Graham C; Wild SH; Slack R; Pell JP; Newby DE;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):236-42. PubMed ID: 20442357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID; Colombo A
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.
    Lemesle G; Sudre A; Modine T; Delhaye C; Rosey G; Gourlay T; Bauters C; Lablanche JM
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):470-8. PubMed ID: 18814219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
    Ferreira-González I; Marsal JR; Ribera A; Permanyer-Miralda G; García-Del Blanco B; Martí G; Cascant P; Martín-Yuste V; Brugaletta S; Sabaté M; Alfonso F; Capote ML; De La Torre JM; Ruíz-Lera M; Sanmiguel D; Cárdenas M; Pujol B; Baz JA; Iñiguez A; Trillo R; González-Béjar O; Casanova J; Sánchez-Gila J; García-Dorado D
    Circulation; 2010 Sep; 122(10):1017-25. PubMed ID: 20733100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.
    Hermanides RS; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    EuroIntervention; 2010 May; 6(1):106-11. PubMed ID: 20542805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.